Eyestem is a clinical-stage biotechnology company focused on developing scalable cell replacement therapies for retinal diseases, particularly through its lead product Eyecyte-RPE™, aimed at treating Dry Age-related Macular Degeneration (AMD)
Eyestem is a clinical-stage biotechnology company focused on developing scalable cell replacement therapies for retinal diseases, particularly through its lead product Eyecyte-RPE™, aimed at treating Dry Age-related Macular Degeneration (AMD).